{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Carboxamide moiety", "HIV-1", "HLGP", "Indole", "Inhibitory activity", "Renin"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32394235", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "02"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "05", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.1007/s11030-020-10061-x"], "Journal": {"ISSN": "1573-501X", "JournalIssue": {"Volume": "25", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Feb"}}, "Title": "Molecular diversity", "ISOAbbreviation": "Mol Divers"}, "ArticleTitle": "Synthetic strategies, SAR studies, and computer modeling of indole 2 and 3-carboxamides as the strong enzyme inhibitors: a review.", "Pagination": {"StartPage": "535", "EndPage": "550", "MedlinePgn": "535-550"}, "Abstract": {"AbstractText": ["Indole derivatives have been the focus of many researchers in the study of pharmaceutical compounds for many years. Researchers have investigated the effect of carboxamide moiety at positions 2 and 3, giving unique inhibitory properties to these compounds. The presence of carboxamide moiety in indole derivatives causes hydrogen bonds with a variety of enzymes and proteins, which in many cases, inhibits their activity. In this review, synthetic strategies of indole 2 and 3-carboxamide derivatives, the type, and mode of interaction of these derivatives against HLGP, HIV-1, renin enzyme, and structure-activity studies of these compounds were investigated. It is hoped that indole scaffolds will be tested in the future for maximum activity in pharmacological compounds."]}, "AuthorList": [{"Identifier": ["0000-0002-8760-3837"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. chehardoli@umsha.ac.ir."}], "LastName": "Chehardoli", "ForeName": "Gholamabbas", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Bahmani", "ForeName": "Asrin", "Initials": "A"}], "GrantList": [{"GrantID": "9712147804", "Agency": "Hamadan University of Medical Sciences", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Divers", "NlmUniqueID": "9516534", "ISSNLinking": "1381-1991"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Indoles"}, {"RegistryNumber": "8724FJW4M5", "NameOfSubstance": "indole"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Indoles"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Sundberg RJ. Chem of indoles. New York: Academic Press; 1996."}, {"Citation": "Lin LP, Yuan P, Jiang N, Mei YN, Zhang WJ, Wu HM, Zhang AH, Cao JM, Xiong ZX, Lu Y, X TR. Gene-inspired mycosynthesis of skeletally new indole alkaloids. Org Lett. 2015;17:2610\u20132613. doi: 10.1021/acs.orglett.5b00882.", "ArticleIdList": ["10.1021/acs.orglett.5b00882", "25985278"]}, {"Citation": "Ciulla MG, Kumar K. The natural and synthetic indole weaponry against bacteria. Tetrahedron Lett. 2018;59(34):3223\u20133233. doi: 10.1016/j.tetlet.2018.07.045.", "ArticleIdList": ["10.1016/j.tetlet.2018.07.045"]}, {"Citation": "Meng L, Guo Q, Liu Y, Chen M, Li Y, Jiang J, Shi J. Indole alkaloid sulfonic acids from an aqueous extract of Isatis indigotica roots and their antiviral activity. Acta Pharm Sin B. 2017;7(3):334\u2013341. doi: 10.1016/j.apsb.2017.04.003.", "ArticleIdList": ["10.1016/j.apsb.2017.04.003", "PMC5430897", "28540170"]}, {"Citation": "Xu W, Gavia DJ, Tang Y. Biosynthesis of fungal indole alkaloids. Nat Prod Rep. 2014;31:1474\u20131487.", "ArticleIdList": ["PMC4162825", "25180619"]}, {"Citation": "Shaveta Singh P. Structural optimization of indole based compounds for highly promising anti-cancer activities: structure activity relationship studies and identification of lead molecules. Eur J Med Chem. 2014;74:440\u2013450. doi: 10.1016/j.ejmech.2013.12.047.", "ArticleIdList": ["10.1016/j.ejmech.2013.12.047", "24487192"]}, {"Citation": "Liew LPP, Fleming JM, Longeon A, Mouray E, Florent I, Bourguet-Kondracki ML, Copp BR. Synthesis of 1-indolyl substituted \u03b2-carboline natural products and discovery of antimalarial and cytotoxic activities. Tetrahedron. 2014;70:4910\u20134920. doi: 10.1016/j.tet.2014.05.068.", "ArticleIdList": ["10.1016/j.tet.2014.05.068"]}, {"Citation": "Mehndiratta S, Hsieh YL, Liu YM, Wang AW, Lee HY, Liang LY, Kumar S, Teng CM, Yang CR, Liou JP. Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase inhibitors with anti-inflammatory activity. Eur J Med Chem. 2014;85:468\u2013479. doi: 10.1016/j.ejmech.2014.08.020.", "ArticleIdList": ["10.1016/j.ejmech.2014.08.020", "25113875"]}, {"Citation": "Noreen T, Taha M, Imran S, Chigurpati S, Rahim F, Selvaraj M, Ismail NH, Mohammad JI, Ullah H, Javid MT, Nawaz F, Irshad M, Ali M. Synthesis of alpha amylase inhibitors based on privileged indole scaffold. Bioorg Chem. 2017;72:248\u2013255. doi: 10.1016/j.bioorg.2017.04.010.", "ArticleIdList": ["10.1016/j.bioorg.2017.04.010", "28482265"]}, {"Citation": "Rashid U, Rahim F, Taha M, Arshad M, Ullah H, Mahmood T, Ali M. Synthesis of 2-acylated and sulfonated 4-hydroxycoumarins: in vitro urease inhibition and molecular docking studies. Bioorg Chem. 2016;66:111\u2013116. doi: 10.1016/j.bioorg.2016.04.005.", "ArticleIdList": ["10.1016/j.bioorg.2016.04.005", "27140727"]}, {"Citation": "Taha M, Sultan S, Nuzar HA, Rahim F, Imran S, Ismail NH, Naz H, Ullah H. Synthesis and biological evaluation of novel N-arylidenequinoline-3-carbohydrazides as potent \u03b2-glucuronidase inhibitors. Bioorg Med Chem. 2016;24:3696\u20133704. doi: 10.1016/j.bmc.2016.06.008.", "ArticleIdList": ["10.1016/j.bmc.2016.06.008", "27312423"]}, {"Citation": "Sharma SK, Kumar P, Narasimhan B, Ramasamy K, Mani V, Mishra RK, Majeed AB. Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 6-methyl-4-[1-(2-substituted-phenylamino-acetyl)-1H-indol-3-yl]-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid ethyl esters. Eur J Med Chem. 2012;48:16\u201325. doi: 10.1016/j.ejmech.2011.11.028.", "ArticleIdList": ["10.1016/j.ejmech.2011.11.028", "22154835"]}, {"Citation": "Yamuna E, Kumar RA, Zeller M, Rajendra Prasad KJ. Synthesis, antimicrobial, antimycobacterial and structure\u2013activity relationship of substituted pyrazolo-, isoxazolo-, pyrimido- and mercaptopyrimidocyclohepta[b]indoles. Eur J Med Chem. 2012;47:228\u2013238. doi: 10.1016/j.ejmech.2011.10.046.", "ArticleIdList": ["10.1016/j.ejmech.2011.10.046", "22119150"]}, {"Citation": "Lin LP, Jiang N, Wu H, Mei Y, Yang J, Tan R. Cytotoxic and antibacterial polyketide-indole hybrids synthesized from indole-3-carbinol by Daldinia eschscholzii. Acta Pharm Sin B. 2019;9:369\u2013380. doi: 10.1016/j.apsb.2018.09.011.", "ArticleIdList": ["10.1016/j.apsb.2018.09.011", "PMC6437554", "30972283"]}, {"Citation": "Sajjadifar S, Zolfigol MA, Chehardoli G, Miri S, Moosavi P. Qinoxaline II. A practical efficient and rapid synthesis of new quinoxalines catalyzed by citric acid as a trifunctional bronsted acid at room temperature under green condition. Int J Chemtech Res. 2013;5:422\u2013429."}, {"Citation": "Zolfigol MA, Chehardoli G, Shiri M. Epoxidation of aromatic \u03b1, \u03b2-unsaturated ketones using PVP\u2013H2O2 under mild and heterogeneous conditions. React Funct Polym. 2007;67:723\u2013727. doi: 10.1016/j.reactfunctpolym.2007.05.002.", "ArticleIdList": ["10.1016/j.reactfunctpolym.2007.05.002"]}, {"Citation": "Chehardoli G, Zolfigol MA, Faal-Rastegar T, Mallakpour S, Ghorbani-Choghamarani A. 1,3,5-Triazine-2,4,6-triyltrisulfamic acid (TTSA): a new organic solid acid for the nitrosation of secondary amines and oxidation of urazoles in the presence of NaNO2 under mild and heterogeneous conditions. J Chem Sci. 2009;121(4):441\u2013447."}, {"Citation": "Zolfigol MA, Bagherzadeh M, Chehardoli G, Mallakpour SE, Mamaghani M. Oxidation of urazoles via in situ generation of Cl\u2009+\u2009by using N, N,2,3,4,5,6-heptachloroaniline or a UHP/MCln system under mild conditions. J Chem Res. 2001;9:390\u2013393."}, {"Citation": "Chehardoli G, Mansouri N. New pyrazolone derivatives synthesis: comparison of the catalytic effect of three typically different Br\u00f8nsted acid catalysts on the reaction progression. Iran Chem Commun. 2018;6(4):450\u2013460. doi: 10.30473/icc.2018.4937.", "ArticleIdList": ["10.30473/icc.2018.4937"]}, {"Citation": "Bahmani A, Sharafi-Kolkeshvandi M, Nikpour F. A simple and expedient method for the stepwise synthesis of 2-ethoxy-(4H)-3, 1-benzoxazine-4-ones. Chin Chem Lett. 2012;23(4):434\u2013437."}, {"Citation": "Zolfigol MA, Sajjadifar S, Chehardoli G, Javaherneshan N. Citric acid as an ecient and trifunctional organo catalyst for one-pot synthesis of new indolenines by Fischer\u2019s method at reflux condition in ethanol. Sci Iran. 2014;21(6):2059\u20132065."}, {"Citation": "Silvestri R, Martino GD, Regina GL, Artico M, Massa S, Vargiu L, Mura M, Loi AG, Marceddu T, Colla PL. Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies. J Med Chem. 2003;46:2482\u20132493.", "ArticleIdList": ["12773052"]}, {"Citation": "Silvestri R, Artico M, Martino GD, Regina GL, Loddo R, Colla ML, Colla PL. Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations. J Med Chem. 2004;47:3892\u20133896.", "ArticleIdList": ["15239667"]}, {"Citation": "Ragno R, Coluccia A, Regina GL, Martino GD, Piscitelli F, Lavecchia A, Novellino E, Bergamini A, Ciaprini C, Sinistro A, Maga G, Crespan E, Artico M, Silvestri R. Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide. J Med Chem. 2006;49:3172\u20133184.", "ArticleIdList": ["16722636"]}, {"Citation": "Onda K, Shiraki R, Ogiyama T, Yokoyama K, Momose K, Katayama N, Orita M, Yamaguchi T, Furutani M, Hamada N, Takeuchi M, Okada M, Ohta M, Tsukamoto S-i. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors. Bioorg Med Chem. 2008;16:10001\u201310012.", "ArticleIdList": ["18952447"]}, {"Citation": "Onda K, Suzuki T, Shiraki R, Yonetoku Y, Negoro K, Momose K, Katayama N, Orita M, Yamaguchi T, Ohta M, Tsukamoto S-i. Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a. Bioorg Med Chem. 2008;16:5452\u20135464.", "ArticleIdList": ["18434170"]}, {"Citation": "Sindac JA, Yestrepsky BD, Barraza SJ, Bolduc KL, Blakely PK, Keep RF, Irani DN, Miller DJ, Larsen SD. Novel inhibitors of neurotropic alphavirus replication that improve host survival in a mouse model of acute viral encephalitis. J Med Chem. 2012;55:3535\u20133545.", "ArticleIdList": ["PMC3329717", "22428985"]}, {"Citation": "Shonberg J, Draper-Joyce C, Mistry SN, Christopoulos A, Scammells PJ, Lane JR, Capuano B. Structure\u2009\u2212\u2009activity study of n-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptor. J Med Chem. 2015;58:5287\u20135307.", "ArticleIdList": ["26052807"]}, {"Citation": "Sweidan K, Sabbah DA, Bardaweel S, Dush KA, Sheikha GA, Mubarak MS. Computer-aided design, synthesis, and biological evaluation of new indole-2-carboxamide derivatives as PI3Ka/EGFR inhibitors. Bioorg Med Chem Lett. 2016;26:2685\u20132690.", "ArticleIdList": ["27084677"]}, {"Citation": "Liu Z, Tang L, Zhu H, Xu T, Qiu C, Zheng S, Gu Y, Feng GP, Zhang Y, Liang G. Design, synthesis and structure-activity relationship study of novel indole-2-carboxamide derivatives as anti-inflammatory agents for the treatment of sepsis. J Med Chem. 2016;59:4637\u20134650.", "ArticleIdList": ["27142640"]}, {"Citation": "Duflos M, Nourrisson MR, Brelet J, Courant J, LeBaut G, Grimaud N, Petit JY. N-Pyridinyl-indole-3-(alkyl)carboxamides and derivatives as potential systemic and topical inflammation inhibitors. Eur J Med Chem. 2001;36:545\u2013553.", "ArticleIdList": ["11525845"]}, {"Citation": "Scheiper B, Matter H, Steinhagen H, Stilz U, B\u00f6cskei Z, Fleury V, McCort G. Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors. Bioorg Med Chem Lett. 2010;20:6268\u20136272.", "ArticleIdList": ["20850300"]}, {"Citation": "Boldron C, Besse A, Bordes MF, Tissandi\u00e9 S, Yvon X, Gau B, Badorc A, Rousseaux T, Barr\u00e9 G, Meneyrol J, Zech G, Nazare M, Fossey V, Pflieger AM, Bonnet-Lignon S, Millet L, Briot C, Dol F, H\u00e9rault JP, Savi P, Lassalle G, Delesque N, Herbert JM, Bono F. N-[6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1H-indole-3-carboxamide (SAR216471), a novel intravenous and oral, reversible, and directly acting P2Y12 antagonist. J Med Chem. 2014;57:7293\u20137316.", "ArticleIdList": ["25075638"]}, {"Citation": "Nemoto K, Tanaka S, Konno M, Onozawa S, Chiba M, Tanaka Y, Sasaki Y, Okubo R, Hattori T. Me2AlCl-mediated carboxylation, ethoxycarbonylation, and carbamoylation of indoles. Tetrahedron. 2015;72:734\u2013745. doi: 10.1016/j.tet.2015.12.028.", "ArticleIdList": ["10.1016/j.tet.2015.12.028"]}, {"Citation": "Shi Y, Duan YH, Ji YY, Wang ZL, Wu YR, Gunosewoyo H, Xie XY, Chen JZ, Yang F, Li J, Tang J, Xie X, Yu LF. Amidoalkylindoles as potent and selective cannabinoid type 2 receptor agonists with in vivo efficacy in a mouse model of multiple sclerosis. J Med Chem. 2017;60:7067\u20137083.", "ArticleIdList": ["28726401"]}, {"Citation": "Klabunde T, Wendt KU, Kadereit D, Brachvogel V, Burger HJ, Herling AW, Oikonomakos NG, Kosmopoulou MN, Schmoll D, Sarubbi E, Roedern E, Sch\u00f6nafinger K, Defossa E. Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. J Med Chem. 2005;48:6178\u20136193.", "ArticleIdList": ["16190745"]}, {"Citation": "Kristiansen M, Andersen B, Iversen LF, Westergaard N. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site. J Med Chem. 2004;47:3537\u20133545.", "ArticleIdList": ["15214781"]}, {"Citation": "Oikonomakos NG, Skamnaki VT, Tsitsanou KE, Gavalas NG, Johnson LN. A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Structure. 2000;15:575\u2013584.", "ArticleIdList": ["10873856"]}, {"Citation": "Ercan-Fang N, Gannon MC, Rath VL, Treadway JL, Taylor MR, Nuttall FQ. Integrated effects of multiple modulators on human liver glycogen phosphorylase a. Am J Physiol Endocrinol Metab. 2002;283:E29\u2013E37.", "ArticleIdList": ["12067839"]}, {"Citation": "Loughlin WA. Recent advances in the allosteric inhibition of glycogen phosphorylase. Mini-Rev Med Chem. 2010;10(12):1139\u20131155.", "ArticleIdList": ["20716052"]}, {"Citation": "Rath VL, Ammirati M, LeMotte PK, Fennell KF, Mansour MN, Danley DE, Hynes TR, Schulte GK, Wasilko DJ, Pandit J. Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core. Mol Cell. 2000;6:139\u2013148.", "ArticleIdList": ["10949035"]}, {"Citation": "Madsen NB. The Enzymes. New York: Academic Press; 1986."}, {"Citation": "Newgard CB, Hwang PK, Fletterick RJ. The family of glycogen phosphorylases: structure and function. Crit Rev Biochem Mol Biol. 1989;24:69\u201399.", "ArticleIdList": ["2667896"]}, {"Citation": "Rath VL, Ammirati M, Danley DE, Ekstrom JL, Gibbs EM, Hynes TR, Mathiowetz AM, McPherson RK, Olson TV, Treadway JL, Hoover DJ. Human liver glycogen phosphorylase inhibitors bind at a new allosteric site. Chem Biol. 2000;7:677\u2013682.", "ArticleIdList": ["10980448"]}, {"Citation": "Hoover DJ, Lefkowitz-Snow S, Burgess-Henry JL, Martin WH, Armento SJ, Stock IA, McPherson RK, Genereux PE, Gibbs EM, Treadway JL. Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase. J Med Chem. 1998;41:2934\u20132938.", "ArticleIdList": ["9685232"]}, {"Citation": "Martin WH, Hoover DJ, Armento SJ, Stock IA, McPherson RK, Danley DE, Stevenson RW, Barrett EJ, Treadway JL. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo. Proc Natl Acad Sci USA. 1998;95:1776\u20131781.", "ArticleIdList": ["PMC19188", "9465093"]}, {"Citation": "Liu G, Zhang Z, Luo X, Shen J, Liu H, Shen X, Chen K, Jiang H. Inhibitory mode of indole-2-carboxamide derivatives against HLGPa: molecular docking and 3D-QSAR analyses. Bioorg Med Chem. 2004;12:4147\u20134157.", "ArticleIdList": ["15246091"]}, {"Citation": "Gallant JE, Gerondelis PZ, Wainberg MA, Shulman NS, Haubrich RH, St Clair M, Lanier ER, Hellmann NS, Richman DD. Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance. Antivir Ther. 2003;8:489\u2013506.", "ArticleIdList": ["14760883"]}, {"Citation": "Palella FJJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998;338:853\u2013860.", "ArticleIdList": ["9516219"]}, {"Citation": "Battini L, Bollini M. Challenges and approaches in the discovery of human immunodeficiency virus type-1 non-nucleoside reverse transcriptase inhibitors. Med Res Rev. 2019;39:1235\u20131273.", "ArticleIdList": ["30417402"]}, {"Citation": "Williams TM, Ciccarone TM, MacTough SC, Rooney CS, Balani SK, Condra JH, Emini EA, Goldman ME, Greenlee WJ, Kauffman LR, O\u2019Brien JA, Sardana VV, Schleif WA, Theoharides AD, Anderson PS. 5-Chloro-3-(phenylsulfonyl)indole-2-carboxyamide: a novel nonnucleoside inhibitor of the HIV-1 reverse transcriptase. J Med Chem. 1993;36:1291\u20131294.", "ArticleIdList": ["7683725"]}, {"Citation": "Ragno R, Artico M, Martino GD, Regina GL, Coluccia A, Pasquali AD, Silvestri R. Docking and 3-D QSAR studies on indolyl aryl sulfones. binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives. J Med Chem. 2005;48:213\u2013223.", "ArticleIdList": ["15634015"]}, {"Citation": "Regina GL, Coluccia A, Brancale A, Piscitelli F, Famiglini V, Cosconati S, Maga G, Samuele A, Gonzalez E, Clotet B, Schols D, Est\u00e9 JA, Novellino E, Silvestri R. New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors. J Med Chem. 2012;55:6634\u20136638.", "ArticleIdList": ["22712652"]}, {"Citation": "Regina GL, Coluccia A, Brancale A, Piscitelli F, Gatti V, Maga G, Samuele A, Pannecouque C, Schols D, Balzarini J, Novellino E, Silvestri R. Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide. J Med Chem. 2011;54:1587\u20131598.", "ArticleIdList": ["21366296"]}, {"Citation": "Wuerzner G, Azizi M. Renin inhibition with aliskiren. Clin Exp Pharmacol Physiol. 2008;35:426\u2013430.", "ArticleIdList": ["18307734"]}, {"Citation": "Yokokawa F. Recent progress on the discovery of non-peptidic direct renin inhibitors for the clinical management of hypertension. Expert Opin Drug Discov. 2013;8:673\u2013690.", "ArticleIdList": ["23597043"]}, {"Citation": "Ames MK, Atkins CE, Pitt B. The renin-angiotensin-aldosterone system and its suppression. J Vet Intern Med. 2019;33:363\u2013382.", "ArticleIdList": ["PMC6430926", "30806496"]}, {"Citation": "Campbell DJ. Renin inhibitors - mechanisms of action. Exp Clin Pharmacol. 2009;32:132\u2013135."}, {"Citation": "Matter H, Scheiper B, Steinhagen H, B\u00f6cskei Z, Fleury V, McCort G. Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds. Bioorg Med Chem Lett. 2011;21:5487\u20135492.", "ArticleIdList": ["21840215"]}, {"Citation": "Scheiper B, Matter H, Steinhagen H, B\u00f6cskei Z, Fleury V, McCort G. Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors. Bioorg Med Chem Lett. 2011;21:5480\u20135486.", "ArticleIdList": ["21840218"]}, {"Citation": "Jing T, Feng J, Zuo Y, Ran B, Liu J, He G. Exploring the substructural space of indole-3-carboxamide derivatives binding to renin: a novel active-site spatial partitioning approach. J Mol Model. 2012;18:4417\u20134426.", "ArticleIdList": ["22588582"]}, {"Citation": "Ghasemi JB, Pirhadi S. non-chiral indole-3-carboxamide-based renin inhibitors. Collect Czech Chem Commun. 2011;76:1447\u20131469."}, {"Citation": "Mota EG, Duarte MH, Cunha EFF, Freitas MP. Theoretical design of new indole-3-carboxamide derivatives as renin inhibitors. Med Chem Res. 2015;24:3097\u20133106."}, {"Citation": "Miao JF, Peng YF, Chen S, Gao WJ, Yang QX, Zhu P, Guo J, Tao J, Luo L, Zhang Y, Ling Y. A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects. Eur J Pharmacol. 2018;824:78\u201388.", "ArticleIdList": ["29428472"]}, {"Citation": "Kopinathan A, Draper-Joyce CJ, Szabo M, Scammells PJ, Lane JR, Capuano B Subtle modifications to the indole-2-carboxamide motif of the negative allosteric modulator N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652) yield dramatic changes in pharmacological activity at the dopamine D2 receptor. J Med Chem 62:371-377", "ArticleIdList": ["29890071"]}, {"Citation": "Stec J, Onajole OK, Lun S, Guo H, Merenbloom B, Vistoli G, Bishai WR, Kozikowski AP. Indole-2-carboxamide-based MmpL3 inhibitors show exceptional antitubercular activity in an animal model of tuberculosis infection. J Med Chem. 2016;59:6232\u20136247.", "ArticleIdList": ["27275668"]}, {"Citation": "Zaki H, Belhassan A, Aouidate A, Lakhlifi T, Benlyas M, Bouachrine M. Antibacterial study of 3-(2-amino-6-phenylpyrimidin-4-yl)-N-cyclopropyl-1-methyl-1Hindole-2-carboxamide derivatives: CoMFA, CoMSIA analyses, molecular docking and ADMET properties prediction. J Mol Struct. 2019;1177:275\u2013285."}]}], "History": [{"Year": "2019", "Month": "10", "Day": "29"}, {"Year": "2020", "Month": "2", "Day": "21"}, {"Year": "2020", "Month": "5", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "11"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32394235", "PMC7214098", "10.1007/s11030-020-10061-x", "10.1007/s11030-020-10061-x"]}}]}